international – ciloa.bio

Read more about the article Bio-Sourcing, Ciloa and Intract Pharma launch €3.4m EU project in inflammatory indications with €1.9M subsidies from Eureka Eurostars

Bio-Sourcing, Ciloa and Intract Pharma launch €3.4m EU project in inflammatory indications with €1.9M subsidies from Eureka Eurostars

AB-BIOBETTER, led by Bio-Sourcing, to pioneer development of new oral formulation of adalimumab for inflammatory bowel diseases; offering patients less invasive, more cost-effective and potentially more potent treatment optionsLiège (Belgium), Montpellier (France) and London (UK), May 28, 2024 – Bio-Sourcing, with partners Ciloa and Intract Pharma, today announce the launch of…

0 Comments

May 28, 2024

Office Design

Ciloa secures €5 million for biomedicines and vaccines development

Ciloa secures €5 million for the development of its new generation of biomedicines and vaccines using exosomesThe company finalized a €3.5 million fundraising and obtained €1.5 million in public funding as part of the “Emerging Infectious Diseases and CBRN Threats” call for proposals of the France 2030 investment plan, operated…

0 Comments

March 8, 2022

Bio-Sourcing, Ciloa and Intract Pharma launch €3.4m EU project in inflammatory indications with €1.9M subsidies from Eureka Eurostars

Ciloa secures €5 million for biomedicines and vaccines development

Contact

Quick links